ANGELA PREDA: Open Payments
NPI 1154956878 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 31 payments from 23 companies in 2025. Trend: 2023 $112 · 2024 $4,426 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Heron Therapeutics, Inc. | 1 | $121 |
| Arthrex, Inc. | 1 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| GENZYME CORPORATION | 2 | $65 |
| Celgene Corporation | 2 | $56 |
| Incyte Corporation | 3 | $55 |
| Dilon Technologies, Inc. | 1 | $46 |
| Janssen Biotech, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| EMD Serono, Inc. | 1 | $28 |
Products named: APONVIE, DUPIXENT, REBLOZYL, ENHERTU, HEMOBLAST BELLOWS, DARZALEX, MONJUVI, RYTELO.
Industry payments across CT — which companies pay providers there.
